Skip to content
WeighLab

Layla vs WellMedr

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Layla

Provider comparison

Shoppers who want brand-name Ozempic, Wegovy, Zepbound or Mounjaro with check-ins included and don't need a lower-cost compounded option.

Semaglutide / month
$1,399/moBrand Ozempic, promotional rate
Tirzepatide / month
$1,399/moBrand Mounjaro, promotional rate
Index 57/100 · Grade CChecked October 2026

WellMedr

Affiliate partner

Shoppers who will complete a medical intake before they see a price, in exchange for a brand Ozempic or Zepbound lane and an eight-SKU microdose line on the same account as the compounded plan.

Semaglutide / month
Not disclosedSale price only, no standing rate
Tirzepatide / month
Not disclosed"Starting at" only, no standing rate
Index 54/100 · Grade CChecked August 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Layla has the higher Cost-Efficiency Index: 57/100 versus 54/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Layla
Coverage not published
WellMedr
50 states claimed, no list published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Layla

WellMedr

Semaglutide / month
Layla: $1,399/moBrand Ozempic, promotional rate
WellMedr: Not disclosedSale price only, no standing rate
Tirzepatide / month
Layla: $1,399/moBrand Mounjaro, promotional rate
WellMedr: Not disclosed"Starting at" only, no standing rate
Semaglutide / year (modeled)
Layla: $16,788
WellMedr: —
Tirzepatide / year (modeled)
Layla: $16,788
WellMedr: —
State availability
Layla: Coverage not published
WellMedr: 50 states claimed, no list published
Oral / sublingual option listed
Layla: Not listed
WellMedr: Yes
Brand-name access listed
Layla: Yes
WellMedr: Yes
Provider facts checked
Layla: October 2026
WellMedr: August 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Layla

Shoppers who want brand-name Ozempic, Wegovy, Zepbound or Mounjaro with check-ins included and don't need a lower-cost compounded option.

Reasons to consider it

  • All-inclusive pricing bundles health check-ins, telehealth visits, prescription and unlimited doctor messaging into one price
  • Names its Medical Director (Dr. Ruth Cohen) on its site
  • LegitScript-certified badge displayed; fast 2-3 day shipping claimed

What to weigh up

  • Brand-only and expensive: the real floor is $1,399/mo (Ozempic/Mounjaro), not the $1,299 the homepage FAQ separately claims — the two figures don't reconcile
  • The lowest Zepbound figure shown ($1,599) is a one-time new-customer discount off a $1,699 standing price, not an ongoing rate
  • No compounded or lower-cost option on the current site, and states served are not published

WellMedr

Shoppers who will complete a medical intake before they see a price, in exchange for a brand Ozempic or Zepbound lane and an eight-SKU microdose line on the same account as the compounded plan.

Reasons to consider it

  • The compounding caveat sits ON the pricing page beside the plan cards rather than in a footer: "Compounded medications are regulated by state Boards of Pharmacy, but are not evaluated by the FDA for safety or efficacy," printed with explicit thyroid C-cell tumor and medullary thyroid carcinoma warnings
  • Both halves of the supply chain are named and checkable — OpenLoop Healthcare Partners, PC and its state professional corporations as the prescribing group in the telehealth consent, and Mycelium Pharmacy as the fulfillment pharmacy in the HIPAA notice
  • The tirzepatide card states "Same price regardless of dosage," so titrating up does not re-price that plan — the single most common way a cheap first month becomes an expensive fourth one

What to weigh up

  • No standing month-to-month rate is published for either compounded drug. The monthly-plan cards say "Starting At $49 a month" and "Starting At $89 a month" under a "Fall sale discount" banner, the same page offers new customers "$150 off for Life," and neither says what the plan costs without them; the intake asks for your height and weight before it shows any price
  • The billing cycle is stated two ways: the plan cards say medication is "shipped every 4 weeks" while the Refund and Cancellation Policy says the subscription "will automatically renew every 21 days." One is 13 charges a year and the other about 17 — neither is the 12 that "a month" implies
  • The pricing page's "MONEY BACK GUARANTEE — IF YOU DON'T LOSE WEIGHT IN 90 DAYS WE WILL REFUND 100% OF YOUR MONEY!" has no counterpart in the policy, which says an order is "final and non-refundable" once the intake is approved and that no refund is issued for a renewal you failed to cancel in time

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

LaylaWellMedr
Normalized Cost/Month
Layla:
41/100
WellMedr:
45/100
Price Transparency
Layla:
78/100
WellMedr:
34/100
Nationwide Access
Layla:
24/100
WellMedr:
70/100
Formulation Options
Layla:
79/100
WellMedr:
84/100
Clinical Oversight
Layla:
81/100
WellMedr:
70/100
Contract Flexibility
Layla:
55/100
WellMedr:
30/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.